-The Business Standard NC Saxena, a former member of the National Advisory Council believes that the regulatory regime in the states continues to be oppressive. In an e-mailed interview with Aditi Phadnis, Saxena says that the fundamental problem in India is the low tax-GDP ratio and neither the last government nor the current one seems interested in increasing revenues. Edited excerpts: * The new government appears to be watering down a lot...
More »SEARCH RESULT
Total Matching Records found : 3986
Urban women in 50s prone to breast cancer -Malathy Iyer
-The Times of India MUMBAI: Debunking the popular belief that the incidence of breast cancer is rising among India's younger women, doctors from Indian's premier cancer hospital in Parel say the typical patient is, more often than not, in her 50s and lives in an urban area. "We have conducted a 20-year analysis of breast cancer rates among the Indian population and found that while the rate of breast cancer is definitely...
More »Subramanian till recently had opposed India on IPR
-The Times of India The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations. Subramanian...
More »Climate change a Public health issue: Jairam
-The Hindu Chennai: There is accumulating evidence in India that pollution and contamination are becoming a serious Public health issue, which requires focussed strategies to mitigate. "Environment in India is not a lifestyle issue. The missing dimension in the environment debate is the Public health debate. One way of getting a larger political focus for environmental issues would be to pitch it as a Public health issue," said Jairam Ramesh, former Union...
More »Pvt sector deserts war on TB, funding down 33% since 2011 -Subodh Varma
-The Times of India Even as tuberculosis (TB) continues to haunt the world, a new study has revealed that funding for research and development of new drugs to fight the disease is floundering. Private sector funding has declined by more than a third since 2011 as pharma companies are closing their TB research programmes. Pfizer shut down its TB drug discovery programme in 2012, AstraZeneca in 2013 and Novartis in 2014. Meanwhile,...
More »
